Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

Clinical trial NCT04586335 · TERMINATED

Trial details

NCT number: NCT04586335
Sponsor: Haihe Biopharma Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Breast Cancer Solid Tumor Prostate Cancer Endometrial Cancer

Start date: 2020-09-28
Primary completion: 2023-02-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.